Treatment of severe idiopathic pulmonary fibrosis-is sildenafil the next (in)stage?
- PMID: 30962967
- PMCID: PMC6409281
- DOI: 10.21037/jtd.2018.12.33
Treatment of severe idiopathic pulmonary fibrosis-is sildenafil the next (in)stage?
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Comment on
-
Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis.N Engl J Med. 2018 Nov 1;379(18):1722-1731. doi: 10.1056/NEJMoa1811737. Epub 2018 Sep 15. N Engl J Med. 2018. PMID: 30220235 Clinical Trial.
References
-
- Galie N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 2016;37:67-119. 10.1093/eurheartj/ehv317 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources